Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin …

CA Bousman, JM Stevenson… - Clinical …, 2023 - Wiley Online Library
Serotonin reuptake inhibitor antidepressants, including selective serotonin reuptake
inhibitors (SSRIs; ie, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and …

Cytochrome P450 enzymes and drug metabolism in humans

M Zhao, J Ma, M Li, Y Zhang, B Jiang, X Zhao… - International journal of …, 2021 - mdpi.com
Human cytochrome P450 (CYP) enzymes, as membrane-bound hemoproteins, play
important roles in the detoxification of drugs, cellular metabolism, and homeostasis. In …

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy

KR Crews, AA Monte, R Huddart… - Clinical …, 2021 - Wiley Online Library
Opioids are mainly used to treat both acute and chronic pain. Several opioids are
metabolized to some extent by CYP2D6 (codeine, tramadol, hydrocodone, oxycodone, and …

A Review of the Important Role of CYP2D6 in Pharmacogenomics

C Taylor, I Crosby, V Yip, P Maguire, M Pirmohamed… - Genes, 2020 - mdpi.com
Cytochrome P450 2D6 (CYP2D6) is a critical pharmacogene involved in the metabolism of~
20% of commonly used drugs across a broad spectrum of medical disciplines including …

Pharmacogenetics guidelines: overview and comparison of the DPWG, CPIC, CPNDS, and RNPGx guidelines

H Abdullah-Koolmees, AM Van Keulen… - Frontiers in …, 2021 - frontiersin.org
Many studies have shown that the efficacy and risk of side effects of drug treatment is
influenced by genetic variants. Evidence based guidelines are essential for implementing …

Association of CYP2C19 and CYP2D6 poor and intermediate metabolizer status with antidepressant and antipsychotic exposure: a systematic review and meta …

F Milosavljević, N Bukvić, Z Pavlović, Č Miljević… - JAMA …, 2021 - jamanetwork.com
Importance Precise estimation of the drug metabolism capacity for individual patients is
crucial for adequate dose personalization. Objective To quantify the difference in the …

Review and consensus on pharmacogenomic testing in psychiatry

CA Bousman, SA Bengesser, KJ Aitchison… - …, 2021 - thieme-connect.com
The implementation of pharmacogenomic (PGx) testing in psychiatry remains modest, in part
due to divergent perceptions of the quality and completeness of the evidence base and …

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics

L Beunk, M Nijenhuis, B Soree… - European Journal of …, 2024 - nature.com
Abstract The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate
pharmacogenetics implementation in clinical practice by developing evidence-based …

Phenoconversion of cytochrome P450 metabolism: a systematic review

SD Klomp, ML Manson, HJ Guchelaar… - Journal of Clinical …, 2020 - mdpi.com
Phenoconversion is the mismatch between the individual's genotype-based prediction of
drug metabolism and the true capacity to metabolize drugs due to nongenetic factors. While …

PharmVar GeneFocus: CYP2C19

MR Botton, M Whirl‐Carrillo… - Clinical …, 2021 - Wiley Online Library
The Pharmacogene Variation Consortium (PharmVar) catalogues star (*) allele
nomenclature for the polymorphic human CYP2C19 gene. CYP2C19 genetic variation …